Europe
-
Novartis spin off looks to build on jubilant reception it had last month in Swissies -
French biotech company is raising capital for R&D and debt refinancing
-
The small amount of deals expected are not likely to come until Q2 or Q3
-
Sector shunned by capital markets finally posts encouraging figures
-
Insurance-linked firm will combine with Financials Acquisition Corp, the London-listed blank cheque company
-
Government bond yields fall as bankers debate HICP 'trigger'
-
◆ Issuer attracts €3.6bn book with just 5bp NIP ◆ Despite challenging backdrop and frequency of issuance, BFCM achieves 'solid' outcome ◆ Eight year tenor meets bid for duration
-
-
BTP's overnight performance helped secure domestic interest
-
-
ING analysts forecast historically low net issuance of €50bn in 2024
-
A company missing its numbers so soon after its IPO is not normal
